Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 86 Results

November 12, 2020

Surrozen to Present at the Stifel 2020 Virtual Healthcare Conference

October 29, 2020

Surrozen Appoints Charles Williams as Chief Financial Officer

October 15, 2020

Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody,for the Treatment of Severe Alcoholic Hepatitis

September 25, 2020

Surrozen Expands Board of Directors with Appointment of David J. Woodhouse,Ph.D.

September 16, 2020

Surrozen to Present at Morgan Stanley 18th Annual Global Healthcare Conference

August 19, 2020

Surrozen Announces Publication of Second Antibody Platform Technology in Scientific Reports

June 19, 2020

UPDATE — Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

June 19, 2020

Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

May 4, 2020

Surrozen Announces Publication of Two Abstracts Providing Evidence for Liver-Targeted Tissue Regeneration

April 6, 2020

Surrozen Scientific Founder Roel Nusse,PhD Receives Prestigious Canada Gairdner International Award for Biomedical Research

«...5 6 789 »

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

FCOI Policy
Accessibility

Scroll to Top